GLP-1 and Hair Loss: Causes, Prevention, and What Helps

Key takeaways

• GLP-1 hair loss is telogen effluvium (TE), a stress-shedding response to rapid weight loss, not permanent damage to hair follicles
• Risk is highest when weight loss exceeds 5 lb/week or when pre-existing nutrient deficiencies (iron, zinc, vitamin D) are present
• Tirzepatide has your strongest association because it produces the most weight loss; semaglutide hair loss appears dose-dependent
• Most shedding resolves within 3–6 months once weight loss stabilizes or the trigger is addressed
• Proactive nutrient supplementation (iron, zinc, biotin, vitamin D) may reduce severity

Does GLP-1 cause hair loss?

According to Dr. Paradi Mirmirani, dermatologist and co-author of the Gupta et al. 2026 systematic review on GLP-1 therapies and hair loss, the association between GLP-1 medications and hair shedding is real but the mechanism is primarily indirect. The drug itself won't damage your follicles; rapid weight loss and nutrient depletion do.

The short answer: GLP-1 medications are associated with hair loss, but the mechanism is indirect. The drugs don't damage hair follicles, rapid weight loss does. When your body loses weight quickly, it experiences metabolic stress. That stress signals some hair follicles to shift prematurely from the growth phase (anagen) into the resting phase (telogen), and then to shedding. This is telogen effluvium, and it's the same type of hair loss seen after major surgery, severe illness, crash dieting, and childbirth.

A 2026 systematic review by Gupta et al. (Science Progress, PMC 13100445) analyzed 24 studies, including pharmacovigilance databases, retrospective cohort studies, and clinical trial data, and found that semaglutide and tirzepatide demonstrated the highest incidence of hair loss among GLP-1 medications. The key finding: tirzepatide, which produces the most weight loss (up to 22.5% body weight), was most frequently linked to telogen effluvium. Semaglutide hair loss appeared to be dose-dependent, doses below 2mg weekly were rarely associated with hair loss, while higher obesity-treatment doses were more commonly implicated.

Why do GLP-1 medications trigger hair shedding?

1. Rapid weight loss → metabolic stress → telogen effluvium

Your hair follicles are metabolically active organs. During rapid caloric restriction, your body prioritizes key functions over hair growth. Follicles that would normally stay in the growth phase for 2–7 years prematurely shift to the resting phase. After 2–3 months in telogen, those hairs fall out, which is why hair shedding typically appears 2–4 months after starting GLP-1 therapy or after a significant dose increase, not immediately. Because rapid loss is the trigger, how fast weight comes off on each GLP-1 is directly relevant here.

A 2026 narrative review in the Brazilian Journal of Hair Health characterized telogen effluvium during weight loss interventions as "a clinical marker of transient systemic disequilibrium rather than permanent follicular damage." In other words, your follicles aren't destroyed, they're temporarily shut down. Once your metabolic stress resolves, they resume normal cycling.

2. Nutrient deficiency compounds the problem

Hair follicles are nutrient-hungry. Iron, zinc, biotin, vitamin D, and protein are all necessary for normal hair cycling. You eat significantly less food, which means less of these nutrients coming in. Urbina et al. (2026) found that GLP-1 users had 26–30% lower ferritin Urbina 2026 levels than comparators, 13.6% developed vitamin D deficiency by 12 months, and B vitamin deficiencies rose over time. Johnson et al. (2025) PubMed found that 64% of GLP-1 users didn't meet iron intake Johnson 2025 recommendations.

Low ferritin is particularly relevant, even "normal" ferritin (15–40 ng/mL) can be suboptimal for hair health. Many dermatologists recommend ferritin above 50 The American Academy of Dermatology (AAD) recognizes iron deficiency as a common contributor to non-scarring hair loss. –70 ng/mL for optimal hair growth. If you're on a GLP-1 medication and experiencing hair thinning, getting your ferritin and vitamin D levels tested is the single most actionable first step.

3. Protein-energy malnutrition

When caloric intake drops below what your body needs for basic maintenance, protein gets diverted from hair production to more critical functions. If you consistently eat below 1,000–1,200 calories or don't prioritize protein, you're at higher risk. Clinical guidance typically recommends at least 1.0–1.2 g of protein per kg of body weight per day during GLP-1 therapy.

How common is GLP-1 hair loss?

Is your hair loss from GLP-1 or pattern baldness?

You'll want to distinguish telogen effluvium from androgenetic alopecia (AGA, or pattern hair loss), because the treatments and prognoses are completely different. Both can occur simultaneously in patients, which makes diagnosis more complex.

Telogen effluvium vs androgenetic alopecia: diagnostic comparison

Feature	Telogen Effluvium (TE)	Androgenetic Alopecia (AGA)
Pattern	Diffuse, all-over thinning	Crown thinning, receding hairline, widened part
Onset	2–4 months after trigger	Gradual, progressive
Duration	Self-resolves in 3–6 months	Does not self-resolve
Cause	Metabolic stress, nutrient deficiency	Genetic + hormonal (DHT)
Treatment	Address trigger, nutrient repletion	Minoxidil, finasteride, PRP

If hair loss follows a patterned distribution (crown, temples, widening part line) rather than diffuse shedding, or if it persists beyond 6–9 months despite stable weight and adequate nutrition, see a dermatologist. GLP-1-related weight loss can unmask or accelerate pre-existing androgenetic alopecia through hormonal shifts, particularly changes in insulin sensitivity, SHBG levels, and androgen metabolism.

How do you treat and prevent GLP-1 hair loss?

Step 1: Test your nutrient levels

Before anything else, get bloodwork. The most relevant tests for GLP-1 hair loss are: ferritin (target >50 ng/mL for hair health), vitamin D (target 40–60 ng/mL), zinc, and B12. If any of these are low, addressing the deficiency is the most impactful intervention. Many people see significant improvement from nutrient repletion alone.

Step 2: Improve nutrition

Protein is the building block of hair (keratin). During GLP-1 therapy, when you're eating less food overall, prioritizing protein at every meal is critical. Aim for at least 1.0–1.2 g of protein per kg of body weight daily. Iron-rich foods (red meat, spinach, lentils), zinc-rich foods (oysters, pumpkin seeds, beef), and foods high in biotin (eggs, nuts) support the raw materials hair needs to grow.

Step 3: Consider targeted supplementation

A GLP-1 companion supplement that includes iron, zinc, biotin, and vitamin D addresses the most common nutritional drivers of GLP-1-related hair shedding. Our GLP-1 Companion Supplement was formulated around the Urbina 2026 research on GLP-1 nutrient gaps and includes chelated iron (18mg), zinc bisglycinate (20mg), biotin (5mcg), and vitamin D3 (50mcg). These aren't hair-growth claims, they're nutrient repletion to fill the gaps that reduced food intake creates.

Step 4: Slow the rate of weight loss if possible

The faster the weight loss, the higher your hair shedding risk. If hair loss is a primary concern, discuss with your doctor whether a slower titration schedule or holding at a lower dose might balance weight loss goals with hair preservation. Weight loss of 1–2 lb/week carries less TE risk than 3–5 lb/week.

Step 5: Be patient

Telogen effluvium is self-limiting. The shedding looks alarming but represents follicles catching up on delayed transitions, once the metabolic stress stabilizes, your follicles re-enter the growth phase. New growth typically becomes visible 3–6 months after shedding onset. During this period, handle hair gently. Avoid tight hairstyles, harsh chemicals, excessive heat, and resist the urge to stop GLP-1 therapy solely because of hair shedding, discontinuing your medication won't immediately stop shedding that's already been triggered, and it sacrifices the metabolic benefits.

When does GLP-1 hair loss start?

GLP-1 hair loss typically begins 2–4 months after starting your medication or after a significant dose increase, not immediately. This delay is characteristic of telogen effluvium: the metabolic stress (rapid weight loss, nutrient shift) triggers follicles to enter the resting phase, and those follicles shed 2–3 months later when the growth cycle resets. If you notice hair shedding within the first week of starting GLP-1 therapy, it's likely coincidental or caused by another trigger, not your medication.

The onset timing also correlates with weight loss velocity. Patients who lose weight rapidly during the first 2–3 months are more likely to see shedding at the 4–6 month mark. Slower dose titration and more gradual weight loss may delay or reduce the shedding trigger. Keep a simple log: note your weekly weight loss and when shedding starts, so you and your dermatologist can correlate the timing.

How much hair shedding on GLP-1 is normal?

Normal daily hair loss is 50–100 strands. During telogen effluvium from GLP-1 therapy, this can increase to 200–300+ strands per day at peak shedding. You'll notice it most in the shower drain, on your pillow, and when brushing. The shedding looks alarming, but it represents follicles catching up on delayed transitions, not permanent loss. As long as your shedding is diffuse (evenly spread across your scalp) rather than patterned. Concentrated at the crown, temples, or part line, it's consistent with TE and will resolve.

If you're losing clumps of hair, developing bald patches, or notice a receding hairline, that's not typical telogen effluvium, it could indicate androgenetic alopecia or another condition and you should get a dermatology evaluation. A simple pull test (gently pull on a group of about 60 hairs, if more than 10% come out, that suggests active shedding) can help quantify whether shedding is within the TE range.

What are the best supplements for GLP-1 hair loss?

The best supplements for GLP-1 hair loss target the nutritional deficiencies that drive telogen effluvium: iron. Ferritin optimization is the single most impactful intervention, target ferritin above 50 ng/mL. zinc (necessary for hair follicle cell division, 20–30mg daily chelated zinc), vitamin D3 (deficiency found in 13.6% of users at 12 months, target 40–60 ng/mL), biotin. The most commonly recommended hair supplement, though evidence for biotin in non-deficient individuals is limited. B12. Methylcobalamin form, particularly important given rising B vitamin deficiency in GLP-1 users.

A targeted companion formula covering iron, zinc, vitamin D, biotin, and B12 at doses matched to GLP-1 user needs is more effective than a generic multivitamin. Your goal is nutrient repletion, not hair growth, because correcting the deficiencies documented by Urbina 2026 is the most evidence-based approach to reducing TE severity. For a full comparison of GLP-1 supplement options, see best GLP-1 supplements.

Is GLP-1 hair loss different in women vs men?

Women are more commonly affected by GLP-1-related telogen effluvium than men, primarily because women have a higher baseline rate of TE in general. Hormonal fluctuations, iron deficiency from menstruation, and greater sensitivity to caloric restriction. Women on GLP-1 therapy who are also premenopausal face compounded iron depletion risk: menstrual blood loss plus reduced dietary iron intake from appetite suppression. Ferritin should be on your radar closely in this group.

In men, GLP-1-associated weight loss can unmask or accelerate androgenetic alopecia (male pattern baldness) through hormonal shifts, particularly changes in insulin sensitivity, SHBG (sex hormone-binding globulin), and free testosterone levels. When insulin sensitivity improves rapidly. As it does with GLP-1 therapy and weight loss. SHBG rises, which can alter the androgen profile. Men noticing patterned thinning (receding hairline, crown thinning) on GLP-1 should consider that this may be AGA being unmasked rather than TE, the two require different treatments.

Does GLP-1 hair loss grow back?

Yes. Telogen effluvium is temporary and self-resolving, your hair grows back. Once your metabolic trigger (rapid weight loss, nutrient deficiency) stabilizes, follicles re-enter the growth phase and new hair appears. The timeline: shedding typically peaks 4–6 months after the trigger, then gradually slows over the following 2–3 months. New growth becomes visible as short "baby hairs" along your hairline and throughout your scalp. Full recovery to pre-shedding density can take 6–12 months from the point of maximum shedding.

Two factors can delay regrowth: persistent nutrient deficiency. If ferritin, zinc, or vitamin D remain low, follicles may not fully recover, and continued rapid weight loss (the trigger is ongoing). That's why nutrient testing and supplementation matter, you can't regrow hair efficiently if the building blocks are missing. Patience is necessary: the growth cycle is slow, and checking daily for improvement creates unnecessary anxiety. Track monthly photos instead.

What are the treatment options for GLP-1 hair loss?

GLP-1 hair loss treatment depends on the type of hair loss. For telogen effluvium (diffuse, temporary shedding), the primary treatment is addressing the underlying trigger: correct nutrient deficiencies, make sure you get enough protein intake, and allow your body to stabilize at its new weight. No medication is needed for TE, it resolves on its own once the trigger is removed. For androgenetic alopecia unmasked or worsened by GLP-1 therapy, evidence-based treatments include minoxidil (topical, over-the-counter, 2% or 5%), finasteride (oral, prescription, for men only), spironolactone (oral, prescription, for women), and PRP (platelet-rich plasma) therapy.

What doesn't work: shampoos marketed as "hair loss" products rarely contain active ingredients at therapeutic doses. Biotin supplements only help if you're actually biotin-deficient (which is uncommon). Collagen supplements lack strong evidence for hair regrowth. The most impactful intervention is the simplest: test your nutrient levels (ferritin, vitamin D, zinc, B12) and correct any deficiencies found. This alone resolves the majority of GLP-1-associated TE cases.

Can you prevent GLP-1 hair loss before it starts?

Prevention is possible though not guaranteed. The most evidence-supported approach is optimizing nutrient levels before starting GLP-1 therapy: get baseline bloodwork for ferritin, vitamin D, zinc, and B12; correct any existing deficiencies before beginning medication; and start a companion formula that covers the nutrients you're most likely to become deficient in. Proactive supplementation before deficiencies develop is easier than correcting them after hair shedding has already begun.

Slower dose titration may also reduce risk by producing more gradual weight loss (less metabolic stress on hair follicles). Target weight loss of 1–2 lb/week rather than 3–5 lb/week. Maintain protein intake at 1.0–1.2 g/kg/day minimum throughout treatment. These measures don't eliminate TE risk entirely, some people will experience shedding regardless, but they reduce severity and duration based on the mechanistic understanding of what triggers GLP-1-related hair loss.

Which causes more hair loss, semaglutide or tirzepatide?

Tirzepatide (Mounjaro, Zepbound) is more frequently linked to hair loss than semaglutide (Ozempic, Wegovy) in pharmacovigilance data. The Gupta et al. 2026 systematic review found tirzepatide was most commonly associated with telogen effluvium, while semaglutide showed a dose-dependent pattern: hair loss was rarely reported below 2mg weekly but became more common at higher obesity-treatment doses (2.4mg). The European Academy of Dermatology and Venereology (EADV) presented the first large-scale real-world cohort study on GLP-1 hair loss at its 2025 congress, adding further weight to these findings. This difference likely reflects weight loss magnitude: tirzepatide produces up to 22.5% body weight loss versus about 15% for semaglutide.

Liraglutide (Saxenda) and dulaglutide (Trulicity) are less frequently implicated in hair loss reports. If hair preservation is a primary concern, this information can inform medication selection, though the decision should balance hair loss risk against other factors including weight loss goals, GI tolerability, cardiovascular benefit, and cost. Discuss these trade-offs with your prescribing doctor.

Does Ozempic cause hair loss?

Ozempic (semaglutide 0.25mg–1.0mg, for type 2 diabetes) is less commonly associated with hair loss than Wegovy (semaglutide 2.4mg, for obesity) because of the dose difference. The Gupta 2026 systematic review found semaglutide hair loss was dose-dependent: doses below 2mg weekly were rarely implicated. Since Ozempic's maximum dose is 1.0mg (or 2.0mg in some markets), the hair loss risk is lower than with Wegovy's higher obesity-treatment dose. Some Ozempic users still do experience hair shedding, particularly those who lose weight rapidly on the diabetes-indicated dose.

If you're on Ozempic and noticing hair shedding, the same approach applies: check ferritin, vitamin D, zinc, and B12 levels; make sure you get enough protein intake; and understand that the shedding is most likely temporary telogen effluvium that will resolve as your weight stabilizes.

Does Mounjaro cause hair loss?

Mounjaro (tirzepatide) has your strongest association with hair loss among all GLP-1 medications, according to the Gupta et al. 2026 systematic review of 24 studies. This is primarily because tirzepatide produces the most dramatic weight loss, up to 22.5% of body weight in clinical trials, and greater weight loss magnitude means greater metabolic stress on hair follicles. The SURMOUNT trials reported alopecia as an adverse event in a small but notable percentage of participants.

Mounjaro is a dual GIP/GLP-1 receptor agonist, and whether the GIP component independently contributes to hair follicle effects is not yet established. The clinical approach remains the same regardless of which GLP-1 medication you're on: proactive nutrient monitoring, adequate protein, and patience through the self-resolving TE cycle.

What should your dermatologist know about GLP-1 hair loss?

If you're seeing a dermatologist for hair loss while on GLP-1 therapy, provide three pieces of information: your GLP-1 medication, dose, and start date; your weight loss trajectory. Total pounds lost and over what timeframe.; and your most recent ferritin, vitamin D, and zinc levels. This context gives your dermatologist to distinguish GLP-1-related telogen effluvium from androgenetic alopecia, alopecia areata, or other conditions, which require different treatments.

A dermatologist may perform a scalp biopsy As Dr. Haykal and colleagues noted in their 2025 PubMed Central publication on alopecia and semaglutide, dermatologists need to proactively ask about GLP-1 medication use when evaluating new-onset hair loss. (rarely needed for TE), trichoscopy. Non-invasive microscopic scalp examination, and complete bloodwork. If the diagnosis is TE, the recommendation will typically be nutrient optimization and patience. If the diagnosis is AGA unmasked by GLP-1 therapy, treatment options include minoxidil, finasteride (men), spironolactone (women), or PRP. Some patients have both conditions simultaneously, requiring a combined treatment approach.

How does iron deficiency cause hair loss on GLP-1?

Iron deficiency is the most clinically impactful nutritional driver of hair loss during GLP-1 therapy. Ferritin (stored iron) is depleted when dietary iron intake drops, which happens inevitably when you eat significantly less food. Urbina et al. (2026) found you had 26–30% lower ferritin than comparators. Even ferritin levels that are technically "normal" (15–40 ng/mL) may be suboptimal for hair health, many dermatologists, including the British Association of Dermatologists (BAD), recommend ferritin above 50–70 ng/mL for optimal hair growth.

Iron bisglycinate chelate is the preferred supplemental form for you because it's better absorbed and gentler on your stomach than ferrous sulfate, important when you're already dealing with GLP-1 GI side effects. Our contains 18mg iron bisglycinate (100% DV). If your ferritin is severely low (below 30 ng/mL), your doctor may recommend a higher-dose standalone iron supplement or IV iron infusion, which replenishes stores faster than oral supplementation.

Does low vitamin D make GLP-1 hair loss worse?

Vitamin D deficiency is the most common nutritional deficiency in patients, 13.6% at 12 months (Urbina 2026), and it independently contributes to hair loss by impairing keratinocyte proliferation and hair follicle cycling. Vitamin D receptors are expressed in hair follicles and play a role in anagen (growth phase) initiation. Low vitamin D combined with low iron creates a compounding effect on hair health that is more severe than either deficiency alone.

Target serum 25(OH)D levels of 40–60 ng/mL for optimal hair health. Most you benefit from 2,000–5,000 IU of vitamin D3 (cholecalciferol) daily, depending on baseline levels and sun exposure. Most GLP-1 companion formulas provide 2,000-5,000 IU of vitamin D3. Take vitamin D with a meal containing fat for optimal absorption, fat-soluble vitamins need dietary fat as a carrier.

Can zinc deficiency cause hair shedding on GLP-1?

Zinc is necessary for hair follicle cell division, keratin synthesis, and the structural integrity of the hair shaft. Zinc deficiency causes diffuse hair thinning that overlaps with telogen effluvium, making it both a contributing cause and an amplifying factor for GLP-1-related hair loss. You\'re at higher risk for zinc deficiency because dietary zinc comes primarily from animal proteins, and reduced food intake means reduced zinc intake.

Chelated zinc (zinc bisglycinate or zinc picolinate) is the preferred supplemental form, better absorbed and less likely to cause nausea than zinc oxide or zinc sulfate. The recommended dose is 15–30mg daily. Note that zinc competes with copper for absorption, long-term high-dose zinc supplementation (above 40mg/day) without copper can cause copper deficiency. Our a companion formula gives you 20mg chelated zinc bisglycinate, within the safe range for daily use.

What's the GLP-1 hair loss timeline month by month?

Month 1–2: No visible hair changes. Weight loss begins. If weight loss is rapid (3+ lb/week), follicles may be shifting to telogen phase, but shedding hasn't started yet. Month 3–4: Shedding may begin, typically noticed in the shower or on pillows. This is the delayed response to the metabolic stress from months 1–2. Month 4–6: Peak shedding for most people. It's the most alarming phase but also the turning point. Month 6–9: Shedding gradually slows. New growth appears as short fine hairs. Month 9–12: Hair density progressively normalizes. Full recovery to pre-shedding thickness typically occurs 6–12 months after peak shedding.

This timeline assumes the trigger (rapid weight loss, nutrient deficiency) has been addressed. If weight loss continues aggressively or nutrient deficiencies persist, the shedding cycle can extend. Monthly progress photos (same lighting, same angle) are the most objective way to track recovery, daily mirror checks create unnecessary anxiety because day-to-day changes are invisible.

How much protein do you need to prevent GLP-1 hair loss?

Hair is made of keratin, a protein. When protein intake drops below what your body needs for key functions, hair production is deprioritized, your body diverts amino acids to more critical processes like organ function and immune response. if you eat below 1,000–1,200 calories daily, you often fall short on protein, creating a protein-energy malnutrition state that triggers or worsens telogen effluvium independently of other nutrient deficiencies.

The target protein intake during GLP-1 therapy is at least 1.0–1.2 g/kg of body weight per day, some experts recommend 1.5 g/kg during active weight loss to preserve both muscle and hair. For a 75kg person, that's 75–113g of protein daily. Prioritize protein at every meal: eggs, Greek yogurt, lean poultry, fish, legumes. When appetite is severely suppressed, protein shakes (creatine vs protein) or collagen peptides in coffee can help reach daily targets without requiring large food volumes. Protein adequacy is a foundational pillar, no supplement regimen compensates for insufficient protein intake.

Does biotin help with GLP-1 hair loss?

Biotin (vitamin B7) is the most commonly recommended supplement for hair loss, but the evidence is detailed. Biotin deficiency does cause hair loss, and supplementation helps when a true deficiency exists. The catch is that clinical biotin deficiency is uncommon in the general population. For you, the question is whether reduced food intake creates functional biotin deficiency, this is plausible but not well-studied. Most biotin supplements provide 5,000–10,000 mcg (far exceeding the 30mcg adequate intake), and at those doses, excess biotin is simply excreted in urine.

Important: high-dose biotin supplementation can interfere with certain lab tests, including troponin (heart attack marker), thyroid function tests, and hormone panels, producing falsely raised or falsely low results. If you're taking biotin and have bloodwork scheduled, stop supplementation 48–72 hours before the blood draw and inform your doctor. Our a companion formula contains 5mcg biotin, a modest amount that contributes to daily intake without the lab-interference risks of high-dose standalone biotin supplements.

Watch: expert breakdown

Cleveland Clinic endocrinologist Dr. Kathy Zhou explains why hair loss happens on GLP-1 medications and how you can protect your hair health. Cleveland Clinic is not affiliated with YourHealthier and does not endorse this product.

Should you stop GLP-1 if you're losing hair?

In most cases, no. Stopping your GLP-1 medication won't immediately stop hair shedding that's already been triggered, because telogen effluvium operates on a 2-4 month delay. The follicles that shifted to your resting phase months ago will shed regardless of whether you continue your medication. Discontinuing GLP-1 therapy sacrifices the metabolic, cardiovascular, and weight management benefits without meaningfully shortening the shedding timeline. Instead, focus on addressing the nutritional drivers: correct iron, zinc, vitamin D, and protein deficiencies while continuing your medication under your doctor's supervision.

The exception: if your hair loss is severe, patterned, or accompanied by other concerning symptoms (scalp pain, scarring, or circular bald patches), these may indicate a condition other than telogen effluvium that warrants immediate dermatological evaluation, and your doctor may adjust your medication plan as part of a broader workup. But for the typical diffuse shedding that 10–15% of GLP-1 users experience, staying on your medication and optimizing nutrition is the better path. Some patients ask about lowering the dose instead of stopping, which carries its own tradeoffs.

GLP-1 Hair Loss FAQ

Does GLP-1 cause hair loss?

GLP-1 medications are associated with hair loss, but the mechanism is primarily indirect. The hair shedding is telogen effluvium triggered by rapid weight loss and the nutritional deficiencies that come with significantly reduced food intake, not a direct pharmacological effect on hair follicles. Tirzepatide has the strongest association because it produces the most weight loss. Semaglutide hair loss appears dose-dependent, with higher doses more commonly implicated.

Is GLP-1 hair loss permanent?

No. Telogen effluvium is temporary. The hair follicles are not damaged, they've shifted to a resting phase in response to metabolic stress. Once your trigger (rapid weight loss, nutrient deficiency) is addressed, follicles resume normal cycling and hair regrows. Most people see improvement within 3–6 months of the shedding onset. If hair loss persists beyond 9–12 months or follows a patterned distribution, see a dermatologist to rule out androgenetic alopecia.

How to stop hair loss on GLP-1?

You can't stop active telogen effluvium mid-cycle, once follicles have shifted to telogen, they will shed. But you can shorten the duration and reduce severity by addressing the underlying triggers: test and correct nutrient deficiencies (ferritin, vitamin D, zinc, B12), ensure adequate protein intake (1.0–1.2 g/kg/day), consider a slower titration schedule if weight loss is very rapid, and supplement strategically with the nutrients you're most likely to be deficient in.

Does everyone on GLP-1 lose hair?

No. Studies suggest 10–15% of people report noticeable shedding. Risk factors include rapid weight loss (>5 lb/week), pre-existing nutrient deficiencies, low baseline ferritin, and higher GLP-1 doses. Many people experience no hair changes at all. Proactive nutrient monitoring and supplementation may reduce risk in predisposed individuals.

Which GLP-1 causes the most hair loss?

Tirzepatide (Mounjaro, Zepbound) is most frequently linked to telogen effluvium in pharmacovigilance data, likely because it produces the greatest magnitude of weight loss (up to 22.5% body weight in trials). Semaglutide (Ozempic, Wegovy) is the second most commonly associated, with a dose-dependent relationship. Liraglutide and dulaglutide are less frequently implicated.

Published research cited in this article

All citations describe published research on GLP-1 medications and hair loss. They do not constitute claims about any specific supplement product.

Related Reading

• GLP-1 side effects: the complete guide
• What is GLP-1? How it works, medications, and what you should know
• Natural GLP-1: foods and compounds that support GLP-1

⚠️ *This article is for informational purposes only and does not constitute medical advice. Hair loss has many causes beyond GLP-1 therapy. Consult a dermatologist for persistent or patterned hair loss. Never start, stop, or modify prescription medication without medical supervision. · Editorial Policy · Lab Results

GLP-1 Hair Loss: Key Data

Metric	Value
Incidence rate	10-15% of GLP-1 users
Type	Telogen effluvium (temporary)
Resolution	3-6 months post-onset
Highest risk medication	Tirzepatide (most weight loss)
Source: Gupta et al. 2026 systematic review — 24 studies, PMC 13100445

Chart: GLP-1 Hair Loss Key Data. Incidence: 10-15% of users. Type: Telogen effluvium (temporary). Resolution: 3-6 months. Highest risk: Tirzepatide. Gupta et al. 2026.